Breaking News

Wheeler Bio Closes $14 Million Seed Financing Round

Funding will be used to expand access to its portable CMS solution.

Author Image

By: Charlie Sternberg

Associate Editor

Wheeler Bio, a biomanufacturing company, recently closed a $14 million Seed financing round co-led by Echo Investment Capital and Alloy Therapeutics, with participation from Floating Point and Presbyterian Health Foundation.   The new funding will be used by Wheeler Bio to expand its team and make its Portable CMC solution more broadly available, partnering with more preclinical CROs and antibody drug developers. Through parallel integration with preclinical drug discovery groups, Portable CMC p...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters